-+ 0.00%
-+ 0.00%
-+ 0.00%

CTS Q3 2026 diluted EPS rises 33% to $0.61

PUBT·10/27/2026 12:03:28
Listen to the news
CTS Q3 2026 diluted EPS rises 33% to $0.61
  • CTS third-quarter 2026 diluted EPS rose 33% year over year to $0.61.
  • Sales increased 5% year over year to $149.6 million, driven by strength across its increasingly diversified portfolio.
  • Operating cash flow jumped 50% year over year to $43.5 million.
  • The Millar acquisition advanced diversification, particularly in the medical end market.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CTS Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-432724), on October 27, 2026, and is solely responsible for the information contained therein.